Диссертация (1139557), страница 48
Текст из файла (страница 48)
192–199.199. Rivers E. P., McCord J., Otero R. et al. Clinical utility of B-type natriuretic peptidein early severe sepsis and septic shock// J. Intensive Care Med. – 2007. – Vol. 22. – Р.363 – 373.200. Roch A. What does high NT-pro-BNP mean in septic shock patients? A part of the puzzle// Crit. Care.
- 2007. - Vol.11(2). - P. 122.201. Roep B. O., Engel N. K., Halteren A. G. S. et al. Modulation of autoimmunity tobeta-cell antigens by proteases// Diabetologia. — 2002. — Vol. 45. — P. 686–692.202. Ruiz-Rodríguez J.C., Caballero J., Ruiz-Sanmartin A. et al. Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study//Med. Intensiva. – 2012. - Oct;36(7). – Р. 475-480.203. Sakhuja R., Green S., Oestreicher E.M. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heartfailure// Clin.
Chem. – 2007. – Vol. 53(3). – Р. 412-420.313204. Samraj R.S., Zingarelli B., Wong H.R. Role of biomarkers in sepsis care// Shock.– 2013. – Vol. 40. – P. 358-365.205. Sande M.A., Lee B.L., Mills J., Chambers H.F. Endocarditis in intravenous dragusers// New York: Raven Press. – 1992. - P.345-359.206. Savill J., Fadok V. Corpse clearance defines the meaning of cell death// Nature. –2000. – Vol.
407. – P.784–788.207. Schuetz P., Daniels L.B., Kulkarni P. et al. Procalcitonin: а new biomarker for thecardiologist// Int. J. Cardiol. – 2016. - Nov 15; 223. -Р. 390-397.208. Seizer P, Rockenstiehl M, Fateh-Moghadam S et al.// Dtsch Med. Wochenschr. –2016. - Sep;141(19). – Р. 1386.209. Shiue A.B., Stancoven A.B., Purcell J.B. et al. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis// Am. J. Cardiol.
–2010. - Oct 1;106(7). - Р. 1011-1015.210. Shor R., Rozenman Y., Bolhinsky A. et al. BNP in septic patients without systolicmyocardial dysfunction// Eur. J. Intern. Med. - 2006. – Vol.17. - P. 536-540.211. Shozushima T., Takahashi G., Matsumoto N. et.al. Usefulness of presepsin(sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome// J.
Infect.Chemother. – 2011. – Vol.17(6). – P. 764-769.212. Shun C.T., Lu S.Y., Yeh C.Y. et.al. Glucosyltransferases of viridans streptococciare modulins of interleukin-6 induction in infective endocarditis// Infect. Immun. – 2005.- Jun;73(6). – Р. 3261-3270.213. Siciliano R.F., Gualandro D.M., Mueller C. et.al. Incremental value of B-type natriuretic peptide for early risk prediction of infective endocarditis// Int. J. Infect. Dis. –2014. - Dec;29. – Р. 120-124.214.
Simon L., Gauvin F., Amre D. K. et al. Serum procalcitonin and C-reactive proteinlevels as markers of bacterial infection: a systematic review and meta-analysis// Clin.Infect. Dis. – 2004. – Vol. 39. – P. 206-217.215. Singh M., Koyfman A. What Is the Role of Procalcitonin in Early Diagnosis ofInfective Endocarditis?// Ann. Emerg. Med. – 2015. - Jul; 66(1) – Р.25-26.314216. Slipczuk L., Codolosa J.N., Davila C.D. Infective endocarditis epidemiology overfive decades: a systematic review// PLoS One. – 2013.
- Dec 9;8(12). - e82665.217. Snipsøyr M.G., Ludvigsen M., Petersen E. et.al. A systematic review of biomarkersin the diagnosis of infective endocarditis// Int. J. Cardiol. – 2016. - Jan 1;202. - Р.564570.218. Sridharan P., Chamberlain R.S. The efficacy of procalcitonin as a biomarker in themanagement of sepsis: slaying dragons or tilting at windmills? Surg. Infect.
(Larchmt). –2013. - Dec; 14(6). - Р. 489-511.219. Stancoven A.B., Shiue A.B., Khera A. et.al. Association of troponin T, detectedwith highly sensitive assay, and outcomes in infective endocarditis// Am. J. Cardiol. –2011. - Aug 1;108(3). – Р. 416-420.220. Takahashi W., Nakada T. A., Yazaki M., Oda S. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units// Shock. – 2016. - Sep; 46(3). – Р.
254-260.221. Tasdelen Fisgin N., Aliyazicioglu Y., Tanyel E. The value of neopterin and procalcitonin in patients with sepsis// South. Med. J. – 2010. - Mar;103(3). - Р. 216-219.222. Thoker Z.A., Khan K.A., Rashid I., Zafar. Correlation of cardiac troponin I levelswith infective endocarditis & its adverse clinical outcomes// Int. J. Cardiol. – 2016.
- Nov1; 222. - Р. 661-664.223. Thuny F., Grisoli D., Collart F. et.al. Management of infective endocarditis:challenges and perspectives// Lancet. – 2012. – Vol. 379(9819). – P. 965–975.224. Thygesen K., Alpert J.S., Jaffe A.S. et al. ESC/ACCF/AHA/WHF Task Force forthe Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction// Eur. Heart J. – 2012. – Vol. 33. – Р. 2551–2567.225. Tomaru Ki.I., Arai M, Yokoyama T. et al.
Transcriptional activation of the BNPgeneby lipopolysaccharide is mediated through GATA elements in neonatal rat cardiacmyocytes// J. Mol. Cell. Cardiol. - 2002. - Jun; 34(6). - P. 649-659.226. Tornos P., Gonzalez-Alujas T., Thuny F., Habib G. Infective endocarditis: the European viewpoint// Curr. Probl. Cardiol. – 2011. - May;36(5). –Р. 175-222.315227. Trimboli P., Seregni E., Treglia G. et al.
Procalcitonin for detecting medullary thyroid carcinoma: a systematic review// Endocr. Relat. Cancer. – 2015. - Vol. 22. Р. 157–164.228. Tsaganos T., Pelekanou A., Skiadas I., Giamarellos-Bourboulis E.J. Differences incytokine stimulation between methicillin-susceptible and methicillin-resistant Staphylococcus aureus in an experimental endocarditis model// J. Infect. Chemother. – 2013. Apr;19(2).
– Р. 272-278.229. Tsenovoy P., Aronow W.S., Joseph J., Kopacz M.S. Patients with infectiveendocarditis and increased cardiac troponin I levels have a higher incidence of in-hospitalmortality and valve replacement than those with normal cardiac troponin I levels//Cardiology. – 2009. – Vol. 112 (3). – P. 202-204.230.
Vanderheyden M., Bartunec J. Brain and other natriuretic peptides: molecular aspects// Eur. J. of Heart. Fail. – 2004. – Vol. 3. – P. 261–267.231. Varpula M., Pulkki K., Karlsson S. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock// Crit. Care Med. - 2007. - Vol. 35(5).
P. 1277-1283.232. Verhagen D.W., Hermanides J., Korevaar J. C. et al. Prognostic value of serial Creactive protein measurements in left-sided native valve endocarditis// Arch. Intern. Med.– 2008. – Vol. 168(3). – P. 302-307.233. Vincent J.L., Donadello K., Schmit X. Biomarkers in the critically ill patient: Creactive protein// Crit.
Care Clin. – 2011. – Vol. 27. – P. 241-251.234. Volk D., Reinke P., Docke W.D. Immunostimulation with cytokines in patientswith immunoparalysis. In: Marshall J.C., Cohen J. Immune response in the critically ill.Berlin: Springer-Verlag – 1999. - P. 393-404.235. Volpe M., Rubattu S., Burnett J. Jr. Natriuretic peptides in cardiovascular diseases:current use and perspectives// Eur. Heart J. – 2014. - Feb;35(7). – Р.
419-425.236. Walborn A., Hoppensteadt D., Syed D. et al. Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines// Clin. Appl.Thromb. Hemost. – 2017. - Jan 1. – Р. 1-8.237. Watkin R.W. Myocardial involvement in infective endocarditis: can serum316troponin levels predict the outcome// Cardiology. – 2009. – Vol. 112(3). – Р. 200-201.238. Watkin R.W., Harper L.V., Vernallis A.B.
et al. Pro-inflammatory cytokines IL6,TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactiveprotein in infective endocarditis// J. Infect. – 2007- Vol.55(3) - Р. 220-225.239. Wei X.B., Liu Y.H., He P.C. et al. Prognostic value of N-terminal prohormonebrain natriuretic peptide for in-hospital and long-term outcomes in patients with infectiveendocarditis// Eur. J. Prev.
Cardiol. – 2017. - May;24(7). – Р. 676-684.240. Weinstock M., Grimm I., Dreier J. et al. Genetic variants in genes of the inflammatory response in association with infective endocarditis// PLoS One. – 2014. - Oct9;9(10). - e110151.241. Whang K.T., Vath S.D., Nylen E.S. et al. Procalcitonin and proinflammantory cytokine in interactions in sepsis// Shock. – 1999. – Vol. 12(4). – P. 268-273.242. Wicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker//Ann.Clin. Biochem.
– 2001. – Vol. 38. – P. 483-493.243. Widmer E., Que Y. A., Entenza J. M., Moreillon P. New concepts in the pathophysiology of infective endocarditis// Curr. Infect. Dis. Rep. – 2006. – Vol. 8(4). – Р.271–279.244. Wu A. H., Packer M., Smith A. et al. Analytical and clinical evaluation of the BayerADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure:a multi- site study// Clin. Chem. – 2004. – Vol. 50. – P. 867–873.245. Xu D., Fuster M.M., Lawrence R.
et al. Heparan sulfat regulates VEGF165 andVEGF121 mediated vascular hyperpermeability// J. Biol. Chem. — 2011 — Vol. 286 —P. 737—745.246. Yan S.T., Sun L.C., Jia H.B. et al. Procalcitonin levels in bloodstream infectionscaused by different sources and species of bacteria// Am. J. Emerg. Med. – 2017. Apr;35(4) – Р. 579-583.247. Yang Kuang-Yao, Kuan-Ting Liu, Yu-Chun Chen et al. Plasma soluble vascularendothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septicshock patients: a prospective observational study// Critical Care. – 2011.
– Vol. 15 (1) Р.11.317248. Yu C.W., Juan L.I., Hsu S.C. et al. Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis// Am. J. Emerg. Med. - 2013- Jun;31(6). – Р. 935-941.249. Yu H., Qi Z., Hang C. et al. Evaluating the value of dynamic procalcitonin andpresepsin measurements for patients with severe sepsis// Am. J. Emerg. Med. – 2017. Jun;35(6).
– Р. 835-841.250. Yu S.W., Juan L. I., Wu M. H. et al. Systematic review and meta-analysis of thediagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count forsuspected acute appendicitis// Br. J. Surg. – 2013. – Vol. 100 – Р. 322-329.251. Yucel T., Memis D., Karamanlioglu B. et al. The prognostic value of atrial andbrain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis// Exp.Clin. Cardiol. – 2008.
- Vol. 13. – Р. 183–188.252. Zencir C., Akpek M., Senol S. et al. Association between hematologic parametersand in-hospital mortality in patients with infective endocarditis// Kaohsiung J. Med. Sci.– 2015. - Dec; 31(12). - Р. 632-638.253. Zhang J., Hu Z.D., Song J., Shao J. Diagnostic Value of Presepsin for Sepsis: ASystematic Review and Meta-Analysis// Medicine (Baltimore). – 2015. -Nov;94(47) - Р.2158.254. Zhang Y., Chen A, Song L et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
